Therapeutic Antibodies

Invented by Wesley H. Dehaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber, Pulmatrix Operating Co Inc The market for inhalable dry powders has been steadily growing in recent years, driven by advancements in technology and a growing demand for convenient and effective respiratory treatments. Inhalable dry powders offer a non-invasive and user-friendly alternative …

Invention for Inhalable Dry Powders Read More »

Invented by Mikkel Wandahl Pedersen, Allan Jensen, Per-Johan Meijer, Symphogen AS The market for Anti-HER2 antibodies, compositions, and formulations has been experiencing significant growth in recent years. HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that is overexpressed in certain types of cancer, including breast and gastric cancer. Anti-HER2 antibodies are designed to …

Invention for Anti-HER2 antibodies, compositions and formulations Read More »

Invented by Carlos F. Barbas, III, Hitoshi Ban, Julia Gavrilyuk, Scripps Research Institute The market for tyrosine bioconjugation through aqueous ene-like reactions is experiencing significant growth and is poised to expand even further in the coming years. This emerging field of bioconjugation offers numerous opportunities for researchers and companies in the pharmaceutical, biotechnology, and diagnostic …

Invention for Tyrosine Bioconjugation Through Aqueous Ene-Like Reactions Read More »

Invented by Jackie SHENG, Bo Liu, Gensun Biopharma Inc The market for trispecific antagonists is rapidly expanding, driven by the increasing demand for innovative therapeutic options in various disease areas. Trispecific antagonists are a type of biologic drug that target multiple disease pathways simultaneously, offering the potential for enhanced efficacy and improved patient outcomes. Trispecific …

Invention for Trispecific antagonists Read More »

Invented by Yasmina Noubia Abdiche, Helen Kim Cho, Wei-Hsien Ho, Karin Ute JOOSS, Arvind Rajpal, Sawsan Youssef, Rinat Neuroscience Corp The Market for Anti-PD-1 Antibodies and Their Use In recent years, the field of cancer immunotherapy has witnessed significant advancements, revolutionizing the way we treat various types of cancer. Among the most promising developments is …

Invention for Anti-PD-1 antibodies, and their use. Read More »

Invented by Nadia Harbeck, Ronald E. Kates, Manfred Schmitt, FOEKENS John A, Biomedica Diagnostics Inc The market for methods of selecting treatment regimens in cancer patients and predicting their outcomes has seen significant growth in recent years. As cancer continues to be a leading cause of death worldwide, the need for personalized and effective treatment …

Invention for Methods of selecting treatment regimens in cancer patients and predicting their outcomes Read More »

Invented by Scott Koenig, Ronald L. Wilder, Ezio Bonvini, Leslie S. Johnson, Provention Bio Inc The market for methods of treating autoimmune diseases using monoclonal immunosuppressive antibodies with reduced toxicities is rapidly expanding as researchers and pharmaceutical companies strive to develop safer and more effective treatments for these debilitating conditions. Autoimmune diseases occur when the …

Invention for Methods of treating autoimmune diseases using monoclonal immunosuppressive antibodies with reduced toxicities Read More »

Invented by Jean C. Sung, Michael M. Lipp, Pulmatrix Operating Co Inc The market for monovalent metal cation dry powders for inhalation has been steadily growing in recent years, driven by the increasing prevalence of respiratory diseases and the demand for more effective and convenient treatment options. These dry powders offer several advantages over traditional …

Invention for Monovalent Metal Cation Dry Powders for Inhalation Read More »

Invented by Sayed Shahabuddin Hoseini, Nai-Kong V. Cheung, Memorial Sloan Kettering Cancer Center The market for Anti-CD33 antibody agents has been witnessing significant growth in recent years. CD33 is a cell surface antigen that is primarily expressed on the surface of myeloid cells, including leukemic blasts in acute myeloid leukemia (AML). Anti-CD33 antibody agents are …

Invention for Anti-CD33 antibody agents Read More »

Invented by Yung-Hsiang Kao, Michael W. Laird, Melody Trexler Schmidt, Rita L. Wong, Daniel P. Hewitt, Genentech Inc The market for prevention and reduction of disulfide bonds during recombinant polypeptide production is witnessing significant growth due to the increasing demand for recombinant proteins in various industries such as pharmaceuticals, biotechnology, and food and beverages. Disulfide …

Invention for Prevention and reduction of disulfide bonds during the recombinant polypeptide production Read More »